Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Chaney

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Cancer Research|September 15, 1988
Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell lineS K Mauldin, G Gibbons, S D Wyrick, et al.
Cancer Research|July 1, 1995
Effect of the chemoprotective agent WR-2721 on disposition and biotransformations of ormaplatin in the Fischer 344 rat bearing a fibrosarcomaD C Thompson, S D Wyrick, D J Holbrook, et al.
Journal of Biochemical Toxicology|January 1, 1991
Effects of diethyldithiocarbamate (DDTC) on the plasma biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in Fischer 344 ratsP F Carfagna, S D Wyrick, D J Holbrook, et al.
Oncology Research|January 1, 1996
Cisplatin-induced alterations in the expression of the mRNAs for UV-damage recognition proteinA Vaisman, S Keeney, A F Nichols, et al.
Biochemistry|November 6, 1984
Indirect inactivation of rabbit reticulocyte initiation factor eIF-2 by helenalin and bis(helenalinyl) malonateW L Williams, S G Chaney, I H Hall, et al.
Biochemistry|March 1, 1983
Guanosine 5'-diphosphate 3'-diphosphate levels, carbon source, and ribonucleic acid synthesis in a mutant strain of Escherichia coliS H Reynolds, C K Brantley, J S Harris, et al.
Cancer Investigation|January 1, 1995
Effects of anesthetics on ormaplatin biotransformations in the Fischer 344 ratD C Thompson, S D Wyrick, D J Holbrook, et al.
Biochemical Pharmacology|October 26, 1995
HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721)D C Thompson, S D Wyrick, D J Holbrook, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell linesD A Delmastro, J Li, A Vaisman, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 29, 1999
High-performance liquid chromatographic separation of the biotransformation products of oxaliplatinF R Luo, T Y Yen, S D Wyrick, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Cancer Research|September 15, 1988
Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell lineS K Mauldin, G Gibbons, S D Wyrick, et al.
Cancer Research|July 1, 1995
Effect of the chemoprotective agent WR-2721 on disposition and biotransformations of ormaplatin in the Fischer 344 rat bearing a fibrosarcomaD C Thompson, S D Wyrick, D J Holbrook, et al.
Journal of Biochemical Toxicology|January 1, 1991
Effects of diethyldithiocarbamate (DDTC) on the plasma biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in Fischer 344 ratsP F Carfagna, S D Wyrick, D J Holbrook, et al.
Oncology Research|January 1, 1996
Cisplatin-induced alterations in the expression of the mRNAs for UV-damage recognition proteinA Vaisman, S Keeney, A F Nichols, et al.
Biochemistry|November 6, 1984
Indirect inactivation of rabbit reticulocyte initiation factor eIF-2 by helenalin and bis(helenalinyl) malonateW L Williams, S G Chaney, I H Hall, et al.
Biochemistry|March 1, 1983
Guanosine 5'-diphosphate 3'-diphosphate levels, carbon source, and ribonucleic acid synthesis in a mutant strain of Escherichia coliS H Reynolds, C K Brantley, J S Harris, et al.
Cancer Investigation|January 1, 1995
Effects of anesthetics on ormaplatin biotransformations in the Fischer 344 ratD C Thompson, S D Wyrick, D J Holbrook, et al.
Biochemical Pharmacology|October 26, 1995
HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721)D C Thompson, S D Wyrick, D J Holbrook, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell linesD A Delmastro, J Li, A Vaisman, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 29, 1999
High-performance liquid chromatographic separation of the biotransformation products of oxaliplatinF R Luo, T Y Yen, S D Wyrick, et al.
Pageof 9